Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting.

John MolvinAmra JujićSilvia NavarinOlle MelanderGiada ZoccoliOliver HartmannAndreas BergmannJoachim StruckErasmus BachusSalvatore Di SommaMartin Magnusson

Published in: Open heart (2019)

In two different European AHF cohorts, bio-ADM and penKid perform as suitable biomarkers for early detection of congestion severity and WRF occurrence, respectively, and are associated with pertinent clinical outcomes.

Keyphrases

acute heart failure
heart failure
risk assessment
atrial fibrillation